Legal & General Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $561K | Buy |
26,367
+6,662
| +34% | +$142K | ﹤0.01% | 2412 |
|
|
2025
Q1 | $380K | Buy |
19,705
+9,644
| +96% | +$186K | ﹤0.01% | 2486 |
|
|
2024
Q4 | $180K | Buy |
10,061
+342
| +4% | +$6.1K | ﹤0.01% | 2673 |
|
|
2024
Q3 | $213K | Sell |
9,719
-9,212
| -49% | -$202K | ﹤0.01% | 2673 |
|
|
2024
Q2 | $148K | Sell |
18,931
-98,687
| -84% | -$769K | ﹤0.01% | 2702 |
|
|
2024
Q1 | $487K | Sell |
117,618
-1,386
| -1% | -$5.74K | ﹤0.01% | 2438 |
|
|
2023
Q4 | $311K | Buy |
119,004
+909
| +0.8% | +$2.38K | ﹤0.01% | 2615 |
|
|
2023
Q3 | $221K | Buy |
118,095
+7,480
| +7% | +$14K | ﹤0.01% | 2704 |
|
|
2023
Q2 | $278K | Buy |
+110,615
| New | +$278K | ﹤0.01% | 2658 |
|
|
2022
Q2 | – | Sell |
-2,770
| Closed | -$7K | – | 3643 |
|
|
2022
Q1 | $7K | Hold |
2,770
| – | – | ﹤0.01% | 3471 |
|
|
2021
Q4 | $7K | Hold |
2,770
| – | – | ﹤0.01% | 3521 |
|
|
2021
Q3 | $14K | Buy |
2,770
+391
| +16% | +$1.98K | ﹤0.01% | 3381 |
|
|
2021
Q2 | $18K | Buy |
+2,379
| New | +$18K | ﹤0.01% | 3334 |
|